Article Information
History
- May 11, 2021.
Article Versions
- You are currently viewing Version 1 of this article (May 11, 2021 - 17:18).
- Version 2 (May 14, 2021 - 08:31).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Anar Sanjaykumar Kothary1,*,
- Caroline Mahendra1,*,
- Mingchen Tan1,
- Eunice Jia Min Tan2,
- Jacelyn Phua Hong Yi1,
- Gabriella1,
- Tan Xin Hui Jocelyn1,
- Jessline Stephanie Haruman1,
- Chun Kiat Lee2,
- Benedict Yan2,3 and
- Astrid Irwanto1,4,#
- 1Nalagenetics Pte Ltd, Singapore, Singapore
- 2Department of Laboratory Medicine, National University Health System, Singapore
- 3Stronghold Diagnostics Lab, Agency for Science, Technology and Research, Singapore
- 4Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore
- ↵#corresponding author: astrid{at}nalagenetics.com
↵* equal contribution
Posted May 11, 2021.
Validation of a multi-gene qPCR-based pharmacogenomics panel across major ethnic groups in Singapore and Indonesia
